Spontaneous regression of widespread lesions is a characteristic featu
re of neuroblastoma. One may postulate that the immune response contri
butes to these clinical regressions. Accordingly, we studied the T-cel
l receptor (TCR) repertoire of tumor-infiltrating lymphocytes in eight
neuroblastoma tumors. The expression of 29 V alpha and 24 V beta gene
segment subfamily specificities was analyzed by PCR and compared by c
omputerized densitometry of Southern blots to values obtained in the b
lood. Overall, the TCR repertoire of these eight patients was diverse,
with virtually all V alpha and V beta specificities expressed. Noneth
eless, four of these patients showed V beta 2 gene segment subfamily o
verexpression in the tumor corresponding to local expansion of polyclo
nal T-cell subpopulations. In one patient, this expansion could be due
to local secretion of superantigenic activity, as suggested by the sp
ecific stimulation of murine T cells expressing a human V beta 2 chain
by supernatant of the corresponding neuroblastoma cell line. In addit
ion, high-resolution analysis of the TCR beta transcript complementari
ty-determining region 3 sizes identified three patients (of six studie
d) with marked clonal T-cell expansion in the tumor not seen in the bl
ood. The specific expression of several dominant clonotypes in the tum
or may be related to the recognition of neuroblastomas-specific antige
ns in these patients. Together, these results on the TCR repertoire ex
pressed in vivo may lead to the characterization of putative immune re
sponse mechanisms (i.e., antigen- or superantigen-driven stimulation)
which participate in tumor regression.